These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 32613904)

  • 1. Helical IMRT-Based Stereotactic Body Radiation Therapy Using an Abdominal Compression Technique and Modified Fractionation Regimen for Small Hepatocellular Carcinoma.
    Chen YX; Zhuang Y; Yang P; Fan J; Zhou J; Hu Y; Zhu WC; Sun J; Zeng ZC
    Technol Cancer Res Treat; 2020; 19():1533033820937002. PubMed ID: 32613904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I/II trial of helical IMRT-based stereotactic body radiotherapy for hepatocellular carcinoma.
    Kim JW; Kim DY; Han KH; Seong J
    Dig Liver Dis; 2019 Mar; 51(3):445-451. PubMed ID: 30503296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereotactic body radiation therapy using a respiratory-gated volumetric-modulated arc therapy technique for small hepatocellular carcinoma.
    Jeong Y; Jung J; Cho B; Kwak J; Jeong C; Kim JH; Park JH; Kim SY; Shim JH; Kim KM; Lim YS; Lee HC; Yoon SM
    BMC Cancer; 2018 Apr; 18(1):416. PubMed ID: 29653562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I dose escalation study of helical intensity-modulated radiotherapy-based stereotactic body radiotherapy for hepatocellular carcinoma.
    Kim JW; Seong J; Lee IJ; Woo JY; Han KH
    Oncotarget; 2016 Jun; 7(26):40756-40766. PubMed ID: 27213593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Multi-Institutional Retrospective Study of Repeated Stereotactic Body Radiation Therapy for Intrahepatic Recurrent Hepatocellular Carcinoma.
    Kimura T; Takeda A; Tsurugai Y; Kawano R; Doi Y; Oku Y; Hioki K; Miura H; Nagata Y
    Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1265-1275. PubMed ID: 32712256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase 2 multicenter study of stereotactic body radiotherapy for hepatocellular carcinoma: Safety and efficacy.
    Jang WI; Bae SH; Kim MS; Han CJ; Park SC; Kim SB; Cho EH; Choi CW; Kim KS; Hwang S; Kim JH; Chang AR; Park Y; Kim ES; Kim WC; Jo S; Park HJ
    Cancer; 2020 Jan; 126(2):363-372. PubMed ID: 31747476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes of stereotactic body radiation therapy for small hepatocellular carcinoma.
    Park S; Jung J; Cho B; Kim SY; Yun SC; Lim YS; Lee HC; Park J; Park JH; Kim JH; Yoon SM
    J Gastroenterol Hepatol; 2020 Nov; 35(11):1953-1959. PubMed ID: 32052884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biologically effective dose (BED) of stereotactic body radiation therapy (SBRT) was an important factor of therapeutic efficacy in patients with hepatocellular carcinoma (≤5 cm).
    Sun J; Zhang T; Wang J; Li W; Zhang A; He W; Zhang D; Li D; Ding J; Duan X
    BMC Cancer; 2019 Aug; 19(1):846. PubMed ID: 31455251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment variables related to liver toxicity in patients with hepatocellular carcinoma, Child-Pugh class A and B enrolled in a phase 1-2 trial of stereotactic body radiation therapy.
    Lasley FD; Mannina EM; Johnson CS; Perkins SM; Althouse S; Maluccio M; Kwo P; Cárdenes H
    Pract Radiat Oncol; 2015; 5(5):e443-e449. PubMed ID: 25899219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Stereotactic body radiation therapy for hepatocellular carcinoma: Results from a retrospective multicentre study].
    Scher N; Janoray G; Riet FG; Le Bayon AG; Debbi K; Lévy S; Louisot P; Garaud P; Chajon E; Barillot I; Salamé É; de Crevoisier R; Chapet S; Calais G
    Cancer Radiother; 2019 Apr; 23(2):104-115. PubMed ID: 30952560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcome and toxicity of radiotherapy for inferior vena cava tumor thrombus in HCC patients: A retrospective study.
    Lee SJ; Jang HS; Choi YK
    Medicine (Baltimore); 2021 Jun; 100(25):e26390. PubMed ID: 34160420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of stereotactic body radiation therapy with volumetric modulated arc therapy and high intensity photon beams for hepatocellular carcinoma patients.
    Wang PM; Hsu WC; Chung NN; Chang FL; Jang CJ; Fogliata A; Scorsetti M; Cozzi L
    Radiat Oncol; 2014 Jan; 9():18. PubMed ID: 24410988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotactic body radiation therapy as an alternative treatment for small hepatocellular carcinoma.
    Yoon SM; Lim YS; Park MJ; Kim SY; Cho B; Shim JH; Kim KM; Lee HC; Chung YH; Lee YS; Lee SG; Lee YS; Park JH; Kim JH
    PLoS One; 2013; 8(11):e79854. PubMed ID: 24255719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotactic Body Radiotherapy for Small Unresectable Hepatocellular Carcinomas.
    Yeung R; Beaton L; Rackley T; Weber B; Hamm J; Lee R; Camborde M; Pearson M; Duzenli C; Loewen SK; Liu M; Ma R; Schellenberg D
    Clin Oncol (R Coll Radiol); 2019 Jun; 31(6):365-373. PubMed ID: 30792051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Stereotactic Body Radiation Therapy Combined With or Without Transcatheter Arterial Chemoembolization for Patients With Small Hepatocellular Carcinoma Ineligible for Resection or Ablation Therapies.
    Kimura T; Aikata H; Doi Y; Imano N; Takeuchi Y; Takahashi I; Nishibuchi I; Katsuta T; Kenjo M; Murakami Y; Awai K; Chayama K; Nagata Y
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818783450. PubMed ID: 29963972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes and prognostic factors of cyberknife stereotactic body radiation therapy for unresectable hepatocellular carcinoma.
    Que J; Kuo HT; Lin LC; Lin KL; Lin CH; Lin YW; Yang CC
    BMC Cancer; 2016 Jul; 16():451. PubMed ID: 27405814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic body radiotherapy in patients with hepatocellular carcinoma in a multimodal treatment setting.
    Gerum S; Heinz C; Belka C; Walter F; Paprottka PM; De Toni EN; Roeder F
    Strahlenther Onkol; 2020 Apr; 196(4):334-348. PubMed ID: 31732784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic body radiation therapy as an effective and safe treatment for small hepatocellular carcinoma.
    Zhang T; Sun J; He W; Li H; Piao J; Xu H; Duan X
    BMC Cancer; 2018 Apr; 18(1):451. PubMed ID: 29678159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biologically effective dose (BED) escalation of stereotactic body radiotherapy (SBRT) for hepatocellular carcinoma patients (≤5 cm) with CyberKnife: protocol of study.
    Sun J; Zhang A; Li W; Wang Q; Li D; Zhang D; Duan X
    Radiat Oncol; 2020 Jan; 15(1):20. PubMed ID: 31992327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic ablative radiotherapy versus conventionally fractionated radiotherapy in the treatment of hepatocellular carcinoma with portal vein invasion: a retrospective analysis.
    Yang JF; Lo CH; Lee MS; Lin CS; Dai YH; Shen PC; Chao HL; Huang WY
    Radiat Oncol; 2019 Oct; 14(1):180. PubMed ID: 31640728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.